Skip to main content
. Author manuscript; available in PMC: 2013 Feb 24.
Published in final edited form as: Methods. 2010 Sep 7;53(1):97–101. doi: 10.1016/j.ymeth.2010.09.001

Fig. 2.

Fig. 2

Structural basis of ligand recognition of the PCAF bromodomain. (A) Structure of the PCAF bromodomain in a complex with a HIV TatK50ac peptide showing the acetyl-lysine binding site for the peptide. (B) Surface representations highlighting a small-molecule inhibitor bound to the acetyl-lysine binding pocket in the PCAF bromodomain.